110 results on '"Sharp GB"'
Search Results
2. Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women [corrected] [published erratum appears in AIDS PATIENT CARE STDS 2009 Dec;23(12):1079].
- Author
-
Liu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, Levine A, Robison E, Goparaju L, Ganhdi M, and Merenstein D
- Abstract
To determine prevalence and predictors of complementary and alternative medicine (CAM) use disclosure to health care providers and whether CAM use disclosure is associated with highly active antiretroviral therapy (HAART) adherence among HIV-infected women, we analyzed longitudinal data collected between October 1994 and March 2002 from HIV-infected CAM-using women enrolled in the Women's Interagency HIV Study. Repeated measures Poisson regression models were constructed to evaluate associations of selected predictors with CAM use disclosure and association between CAM use disclosure and HAART adherence. A total of 1,377 HIV-infected women reported CAM use during study follow-up and contributed a total of 4,689 CAM-using person visits. The overall prevalence of CAM use disclosure to health care providers was 36% across study visits. Women over 45 years old, with a college education, or with health insurance coverage were more likely to disclose their CAM use to health care providers, whereas women identified as non-Hispanic Black or other ethnicities were less likely to communicate their CAM usage. More health care provider visits, more CAM domains used, and higher health care satisfaction scores had significant relationships with increased levels of CAM use disclosure. Restricting analysis to use of herbal or nonherbal medications only, similar results were obtained. Compared to other CAM domains, mind-body practice had the lowest prevalence of CAM use disclosure. Additionally, CAM use disclosure was significantly associated with higher HAART adherence. From this study, we showed that a high percentage of HIV-infected women did not discuss their CAM use with health care providers. Interventions targeted towards both physicians and patients may enhance communication of CAM use, avoid potential adverse events and drug interactions, and enhance HAART adherence. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
3. Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women.
- Author
-
Strickler HD, Fazzari M, Kovacs A, Isasi C, Napolitano LA, Minkoff H, Gange S, Young M, Sharp GB, Kaplan RC, Cohen M, Gunter MJ, Harris TG, Yu H, Schoenbaum E, Landay AL, Anastos K, Strickler, Howard D, Fazzari, Melissa, and Kovacs, Andrea
- Abstract
Background: The insulin-like growth factor (IGF) axis has been hypothesized to influence the rate of human immunodeficiency virus (HIV) disease progression. This premise is based largely on laboratory models showing that IGF-I stimulates thymic growth and increases lymphocyte numbers and that IGF-binding protein (IGFBP)-3 has an opposing effect, inhibiting hematopoietic stem cell development.Methods: We studied 1422 HIV-infected women enrolled in a large cohort that entailed semiannual follow-up (initiated in 1994). Baseline serum samples were tested for IGF-I and IGFBP-3 to determine their associations with incident clinical acquired immunodeficiency syndrome (AIDS) and CD4+ T cell count decline prior to April 1996 (before the era of highly active antiretroviral therapy [HAART]).Results: Low IGF-I levels (Ptrend= .02) and high IGFBP-3 levels (Ptrend= .02) were associated with rapid CD4+ T cell count decline. Only IGFBP-3, however, was significantly associated with AIDS incidence (hazard ratio for highest vs. lowest quartile, 2.65 [95% confidence interval, 1.30-5.42]; Ptrend= .02) in multivariable models.Conclusions: These findings suggest that serum levels of IGFBP-3 (and possibly IGF-I) are associated with the rate of HIV disease progression in women and, more broadly, that interindividual heterogeneity in the IGF axis may influence HIV pathogenesis. If correct, the IGF axis could be a target for interventions to slow HIV disease progression and extend the time before use of HAART becomes necessary. [ABSTRACT FROM AUTHOR]- Published
- 2008
- Full Text
- View/download PDF
4. Outcome findings from a multidisciplinary clinic for children with epilepsy... parental rating of clinic quality.
- Author
-
Williams J, Sharp GB, Griebel ML, Knabe MD, Spence GT, Weinberger N, Hendon A, and Rickert V
- Published
- 1995
- Full Text
- View/download PDF
5. Misclassification of nutrient and energy intake from use of closed-ended questions in epidemiologic research.
- Author
-
Tylavsky FA and Sharp GB
- Published
- 1995
- Full Text
- View/download PDF
6. Use of restraint devices to prevent collision injuries and deaths among welfare-supported children.
- Author
-
Sharp GB and Carter MA
- Abstract
Evidence that death and injury rates for young children involved in automobile collisions could be reduced if children were restrained prompted the State of Tennessee to pass the nation's first child passenger law, a law that became effective in January 1978. Although similar laws have now been enacted throughout the United States, usually restraint devices are not provided to low-income groups who may have difficulty affording them. Few studies have examined the use of such devices by welfare recipients. [ABSTRACT FROM AUTHOR]
- Published
- 1992
7. Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.
- Author
-
Althoff KN, Anastos K, Nelson KE, Celentano DD, Sharp GB, Greenblatt RM, French AL, Diamond DJ, Holman S, Young M, Gange SJ, Althoff, Keri N, Anastos, Kathryn, Nelson, Kenrad E, Celentano, David D, Sharp, Gerald B, Greenblatt, Ruth M, French, Audrey L, Diamond, Don J, and Holman, Susan
- Abstract
Objective: To estimate the cumulative incidence of self-reported influenza vaccination ("vaccination coverage") and investigate predictors in HIV-infected women.Methods: In an ongoing cohort study of HIV-infected women in five US cities, data from two influenza seasons (2006-2007 n=1209 and 2007-2008 n=1161) were used to estimate crude and adjusted prevalence ratios (aPR) and 95% confidence intervals ([,]) from Poisson regression with robust variance models using generalized estimating equations (GEE).Results: In our study, 55% and 57% of HIV-infected women reported vaccination during the 2006-2007 and 2007-2008 seasons, respectively. Using data from both seasons, older age, non-smoking status, CD4 T-lymphocyte (CD4) count > or =200 cells/mm(3), and reporting at least one recent healthcare visit was associated with increased vaccination coverage. In the 2007-2008 season, a belief in the protection of the vaccine (aPR=1.38 [1.18, 1.61]) and influenza vaccination in the previous season (aPR=1.66 [1.44, 1.91]) most strongly predicted vaccination status.Conclusion: Interventions to reach unvaccinated HIV-infected women should focus on changing beliefs about the effectiveness of influenza vaccination and target younger women, current smokers, those without recent healthcare visits, or a CD4 count <200 cells/mm(3). [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
8. Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.
- Author
-
Merenstein D, Yang Y, Schneider MF, Goparaju L, Weber K, Sharma A, Levine AM, Sharp GB, Gandhi M, Liu C, Merenstein, Daniel, Yang, Yang, Schneider, Michael F, Goparaju, Lakshmi, Weber, Kathleen, Sharma, Anjali, Levine, Alexandra M, Sharp, Gerald B, Gandhi, Monica, and Liu, Chenglong
- Abstract
Objective: To assess whether complementary and alternative medicine (CAM) use is associated with the timing of highly active antiretroviral therapy (HAART) initiation among human immunodeficiency virus (HIV)-infected participants of the Women's Interagency HIV Study.Study Methods: Prospective cohort study between January 1996 and March 2002. Differences in the cumulative incidence of HAART initiation were compared between CAM users and non-CAM users using a logrank test. Cox regression model was used to assess associations of CAM exposures with time to HAART initiation. MAIN OUTCOME AND EXPOSURES: Study outcome was time from January 1996 to initiation of HAART. Primary exposure was use of any CAM modality before January 1996, and secondary exposures included the number and type of CAM modalities used (ingestible CAM medication, body practice, or spiritual healing) during the same period.Results: One thousand thirty-four HIV-infected women contributed a total of 4987 person-visits during follow-up. At any time point, the cumulative incidence of HAART initiation among CAM users was higher than that among non-CAM users. After adjustment for potential confounders, those reporting CAM use were 1.34 times (95% confidence interval: 1.09, 1.64) more likely to initiate HAART than non-CAM users.Conclusion: Female CAM users initiated HAART regimens earlier than non-CAM users. Initiation of HAART is an important clinical marker, but more research is needed to elucidate the role specific CAM modalities play in HIV disease progression. [ABSTRACT FROM AUTHOR]- Published
- 2008
9. Viremia Trajectories of HIV in HIV-Positive Women in the United States, 1994-2017.
- Author
-
Kassaye SG, Wang C, Ocampo JMF, Wilson TE, Anastos K, Cohen M, Greenblatt RM, Fischl MA, Otofukun I, Adimora A, Kempf MC, Sharp GB, Young M, and Plankey M
- Subjects
- Adult, Antiviral Agents therapeutic use, Female, HIV Infections drug therapy, HIV Infections therapy, Humans, Longitudinal Studies, Middle Aged, Prospective Studies, Risk Factors, United States epidemiology, Viremia drug therapy, HIV Infections epidemiology, Viral Load statistics & numerical data, Viremia epidemiology
- Abstract
Importance: Viral suppression of HIV is an important treatment goal to decrease morbidity, mortality, and risk of transmission to others., Objective: To characterize longitudinal HIV viral load outcomes among women enrolled in the Women's Interagency HIV Study (WIHS)., Design, Setting, and Participants: A prospective cohort study of HIV-positive women with semiannual study visits and a minimum of 5 follow-up visits was conducted from 1994 to 2017. The WIHS sites included in this analysis are in Brooklyn and Bronx, New York; Chicago, Illinois; San Francisco, California; and Washington, DC., Main Outcomes and Measures: Women were categorized into groups based on their probability of achieving viral load suppression below 200 copies/mL using logistic trajectory modeling. Multinomial regression analysis was used to identify factors associated with placement in the group with the highest probability of viremia., Results: At baseline, the mean (SD) age of the 1989 women was 36.9 (8.0) years, mean CD4+ T-lymphocyte count was 467/mm3, median (interquartile range) HIV RNA was 6200.0 (384.5-41 678.0) copies/mL, and 1305 women (65.6%) were African American. Three trajectory groups were identified with low (568 [28.6%]), intermediate (784 [39.4%]), and high (637 [32.0%]) probability of viremia above 200 copies/mL. The mean (SD) cumulative years of viral suppression were 18.7 (4.0) years, 12.2 (3.1) years, and 5.8 (2.9) years in the respective groups. Factors associated with high probability of viremia included younger age (odds ratio [OR]. 0.99; 95% CI, 0.98-0.99; P = .03), African American race (odds ratio [OR], 2.43; 95% CI, 1.75-3.37), P < .001), Hispanic race/ethnicity (OR, 1.50; 95% CI, 1.03-2.19; P = .04), increased levels of depressive symptoms (OR, 1.17; 95% CI, 1.01-1.36; P = .03), drug use (OR, 1.23; 95% CI, 1.01-1.51; P = .04), lower CD4+ T-lymphocyte counts (OR, 95% CI, 0.82; 0.80-0.85; P < .001), and unstable housing (OR, 1.25, 95% CI, 1.03-1.50; P = .02). Between 2015 and 2017, 71.2% of women demonstrated sustained viral suppression: 89.6% (310 of 346) of those with low viremia, 83.4% (346 of 415) with intermediate, and 35.2% (112 of 318) with high probability of viremia., Conclusions and Relevance: This longitudinal approach suggested that the probability of viremia decreased substantially over time for most participants, including among women with earlier histories of incomplete viral suppression. The findings from this study suggest that continued efforts are needed to address mental health, social, behavioral and structural factors that were identified as associated with high probability of HIV viremia over time.
- Published
- 2019
- Full Text
- View/download PDF
10. Bioavailable serum estradiol may alter radiation risk of postmenopausal breast cancer: a nested case-control study.
- Author
-
Grant EJ, Cologne JB, Sharp GB, Eguchi H, Stevens RG, Izumi S, Kim YM, Berrington de González A, Ohishi W, and Nakachi K
- Subjects
- Adult, Aged, Biological Availability, Case-Control Studies, DNA Damage, Female, Humans, Longitudinal Studies, Middle Aged, Postmenopause, Progesterone blood, Radiation, Ionizing, Radiometry, Risk Factors, Testosterone blood, Breast Neoplasms blood, Breast Neoplasms etiology, Estradiol blood, Neoplasms, Radiation-Induced blood, Neoplasms, Radiation-Induced etiology
- Abstract
Purpose: Ionizing radiation and high levels of circulating estradiol are known breast cancer carcinogens. We investigated the risk of first primary postmenopausal breast cancer in relation to the combined effects of whole-body ionizing radiation exposure and prediagnostic levels of postmenopausal sex hormones, particularly bioavailable estradiol (bE
2 )., Materials and Methods: A nested case-control study of 57 incident breast cancer cases matched with 110 controls among atomic bomb survivors. Joint effects of breast radiation dose and circulating levels of sex hormones were assessed using binary regression and path analysis., Results and Conclusion: Radiation exposure, higher levels of bE2 , testosterone and progesterone, and established reproductive risk factors were positively associated with postmenopausal breast cancer risk. A test for mediation of the effect of radiation via bE2 level suggested a small (14%) but significant mediation (p = 0.004). The estimated interaction between radiation and bE2 was large but not significant (interaction = 3.86; p = 0.32). There is accumulating evidence that ionizing radiation not only damages DNA but also alters other organ systems. While caution is needed, some portion of the radiation risk of postmenopausal breast cancer appeared to be mediated through bE2 levels, which may be evidence for cancer risks due to both direct and indirect effects of radiation.- Published
- 2018
- Full Text
- View/download PDF
11. The Incidence Rates and Standardized Incidence Ratios of Cancer in Hemophilic HIV/AIDS Patients in Taiwan.
- Author
-
Chen M, Jen I, Sharp GB, and Chen YM
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, HIV Infections epidemiology, Hemophilia A epidemiology, Humans, Incidence, Leukemia complications, Leukemia epidemiology, Lymphoma, Non-Hodgkin complications, Lymphoma, Non-Hodgkin epidemiology, Middle Aged, Mouth Neoplasms complications, Mouth Neoplasms epidemiology, Neoplasms epidemiology, Taiwan epidemiology, Young Adult, HIV Infections complications, Hemophilia A complications, Neoplasms complications
- Published
- 2016
- Full Text
- View/download PDF
12. Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study.
- Author
-
Yen YF, Jen I, Chen M, Chuang PH, Liu YL, Sharp GB, and Chen YM
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Cohort Studies, Coinfection, Comorbidity, Female, Health Surveys, Humans, Incidence, Male, Middle Aged, Taiwan epidemiology, Young Adult, Acquired Immunodeficiency Syndrome epidemiology, Cytomegalovirus Infections epidemiology, HIV Infections epidemiology, Stroke epidemiology
- Abstract
Objectives: Cytomegalovirus (CMV) infection might increase the risk of cardiovascular event. However, data on the link between incident stroke and co-infections of CMV and human immunodeficiency virus (HIV) are limited and inconsistent. This nationwide population-based cohort study analyzed the association of CMV end-organ disease and stroke among people living with HIV/AIDS (PLWHA)., Methods: From January 1, 1998, this study identified adult HIV individuals with and without CMV end-organ disease in the Taiwan National Health Insurance Research Database. All patients were observed for incident stroke and were followed until December 31, 2012. Time-dependent analysis was used to evaluate associations of CMV end-organ disease with stroke., Results: Of the 22,581 PLWHA identified (439 with CMV end-organ disease and 22,142 without CMV end-organ disease), 228 (1.01%) had all-cause stroke during a mean follow-up period of 4.85 years, including 169 (0.75%) with ischemic stroke and 59 (0.26%) with hemorrhagic stroke. After adjusting for age, sex, comorbidities, opportunistic infections after HIV diagnosis, and antiretroviral treatment, CMV end-organ disease was found to be an independent risk factor for incident all-cause stroke (adjusted hazard ratio [AHR], 3.07; 95% confidence interval [CI], 1.70 to 5.55). When stroke type was considered, CMV end-organ disease was significantly positively associated with the risk of ischemic stroke (AHR, 3.14; 95% CI, 1.49 to 6.62) but not hemorrhagic stroke (AHR, 2.52; 95% CI, 0.64 to 9.91)., Conclusions: This study suggested that CMV end-organ disease was an independent predictor of ischemic stroke among PLWHA.
- Published
- 2016
- Full Text
- View/download PDF
13. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
- Author
-
Kerzerho J, McIlvaine EJ, Anthony P, Mack WJ, Wang CH, Frederick T, Operskalski E, Chen Z, Al-Harthi L, Landay A, Young MA, Tien PC, Augenbraun M, Strickler HD, Akbari O, Golub ET, Sharp GB, and Kovacs A
- Subjects
- Adult, Antiretroviral Therapy, Highly Active, CD4-Positive T-Lymphocytes immunology, Cross-Sectional Studies, Female, HIV Infections complications, HIV Infections drug therapy, Hepatitis C complications, Humans, Middle Aged, Natural Killer T-Cells, Prospective Studies, Viremia, Coinfection, HIV Infections immunology, HIV-1 immunology, Hepacivirus immunology, Hepatitis C immunology, Interleukin-7 blood
- Abstract
Objectives: Hepatitis C virus (HCV) infection causes an alteration in T-cell maturation and activation in patients coinfected with human immunodeficiency virus (HIV). Because interleukin 7 (IL-7) is a major cytokine controlling T-cell homeostasis, we analyzed the potential influence of HCV coinfection on circulating IL-7 levels in HIV-infected women before and after highly active antiretroviral therapy (HAART)., Design and Methods: This prospective study included 56 HIV monoinfected, 55 HIV/HCV coinfected without HCV viremia, 132 HIV/HCV coinfected with HCV viremia, and 61 HIV/HCV-uninfected women for whom plasma levels of IL-7 were determined by enzyme-linked immunosorbent assay at 1 or more follow-up visits before and after HAART. Cross-sectional analyses of the associations between plasma IL-7 levels and HCV infection, demographic, clinical, and immunologic characteristics were evaluated using univariate and multivariate linear regression models before and after HAART., Results: In multivariate models, IL-7 levels were significantly higher in coinfected HCV viremic women than in HIV monoinfected women (multiplicative effect = 1.48; 95% confidence interval: 1.01 to 2.16; P = 0.04) before HAART, but were similar between these two groups among women after HAART. In addition to HCV viremia, higher IL-7 levels were associated with older age (P = 0.02), lower CD4(+) T-cell count (P = 0.0007), and higher natural killer T-cell count (P = 0.02) in women before HAART. Among HAART-treated women, only lower CD4(+) T-cell count was significantly associated with IL-7 level (P = 0.006)., Conclusions: Our data demonstrate that in HIV-infected women, circulating levels of IL-7 are strongly associated with CD4 T-cell depletion both before and after HAART. Our data also demonstrate that HCV viremia increases circulating IL-7 levels before HAART but not after HAART in coinfected women. This suggests that the effect of HCV on lymphopenia is abrogated by HAART.
- Published
- 2016
- Full Text
- View/download PDF
14. A combination of chorea, myoclonus, and dystonia in a patient with pontocerebellar hypoplasia type 2: a video case presentation.
- Author
-
Gupta HV, Ramakrishnaiah RH, Sharp GB, Lee RW, and Walters WD
- Subjects
- Brain pathology, Child, Humans, Magnetic Resonance Imaging, Male, Chorea complications, Dystonia complications, Myoclonus complications, Olivopontocerebellar Atrophies complications, Video Recording
- Published
- 2015
- Full Text
- View/download PDF
15. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes.
- Author
-
Lang Kuhs KA, Kuniholm MH, Pfeiffer RM, Chen S, Desai S, Edlin BR, Peters MG, Plankey M, Sharp GB, Strickler HD, Villacres MC, Quinn TC, Gange SJ, Prokunina-Olsson L, Greenblatt RM, and O'Brien TR
- Subjects
- Adult, Female, Herpes Genitalis genetics, Herpes Labialis genetics, Humans, Prospective Studies, Recurrence, Genotype, Herpes Genitalis pathology, Herpes Labialis pathology, Interleukins genetics
- Abstract
IFNL4-ΔG/TT (rs368234815) genotype is associated with hepatitis C virus clearance and may play a role in other infections. IFN-λ4 protein is generated only in individuals who carry the IFNL4-ΔG allele. The IFNL4 rs12979860-T allele, which is in strong linkage disequilibrium with IFNL4-ΔG, was recently reported to be associated with more frequent and severe oral herpes episodes. We investigated the association of IFNL4-ΔG/TT with herpes simplex virus (HSV)-related outcomes among 2,192 African American and European American participants in the Women's Interagency HIV Study (WIHS). WIHS is a prospective cohort study of human immunodeficiency virus (HIV)-infected and at-risk women that began in 1994. This report includes follow-up through 2013. Available data included: HSV-1 and HSV-2 antibodies at study entry; bi-annually ascertained episodes of (self-reported) oral herpes, (self-reported) genital sores and (clinician-observed) genital ulcers; HSV-2 DNA in cervicovaginal lavage (CVL) specimens. IFNL4-ΔG/TT genotyping was determined by TaqMan. We compared women with IFNL4-ΔG/ΔG or IFNL4-TT/ΔG genotypes (i.e., IFNL4-ΔG carriers) to those with the IFNL4-TT/TT genotype, adjusting for age, race and HIV status. For outcomes with repeated measurements, the adjusted odds ratio (aOR), 95% confidence interval [CI] and p-value were determined using a generalized estimating equations approach. Median participant age at enrollment was 36 years; 81% were African American, 74% were HIV-infected. Among 1,431 participants tested for antibodies, 72.8% were positive for HSV-1 and 79.0% were positive for HSV-2. We observed no association between IFNL4-ΔG/TT genotype and any outcome: HSV-1 or HSV-2 antibody prevalence (p>0.1, all comparisons); oral herpes (aOR, 1.2; p = 0.35); genital sores (aOR, 1.0; p = 0.71); genital ulcers (aOR, 1.1; p = 0.53); detectable HSV-2 DNA in CVL (N = 322; aOR, 0.71; p = 0.49); HSV-2 DNA level (p = 0.68). In this large prospective study, IFNL4-ΔG/TT genotype was not associated with HSV-related outcomes, including episodes of oral or genital herpes.
- Published
- 2015
- Full Text
- View/download PDF
16. Options for pharmacoresistant epilepsy in children: when medications don't work.
- Author
-
Sharp GB, Samanta D, and Willis E
- Subjects
- Child, Humans, Complementary Therapies methods, Drug Resistance, Epilepsy therapy
- Abstract
Medications are often first-line treatment for epilepsy in children. A detailed review of antiepileptic drugs and their application in various epilepsy syndromes is provided in the article "Antiepileptic Drugs--A Review" by Sankaraneni and Lachhwani (this issue). Here, we will focus on nonmedicinal approaches-some fairly longstanding and described since Biblical times such as the ketogenic diet while others are relatively new such as neurostimulation. Yet, others such as cannabinoids have been utilized for centuries for their medicinal properties, but we are just learning the scientific basis behind their efficacy. Families are often interested in nonmedicinal avenues of treatment, and knowledge of these options can empower a pediatrician to help families make choices that have scientific validity., (Copyright 2015, SLACK Incorporated.)
- Published
- 2015
- Full Text
- View/download PDF
17. Absence status after starting clobazam in a patient with syndrome of continuous spike and wave during slow sleep (CSWS).
- Author
-
Samanta D, Willis E, and Sharp GB
- Subjects
- Anticonvulsants administration & dosage, Benzodiazepines administration & dosage, Child, Clobazam, Electroencephalography, Humans, Male, Anticonvulsants adverse effects, Benzodiazepines adverse effects, Developmental Disabilities drug therapy, Epilepsy, Absence chemically induced, Epilepsy, Absence diagnosis, Sleep
- Published
- 2014
- Full Text
- View/download PDF
18. Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009.
- Author
-
Chen M, Jen I, Chen YH, Lin MW, Bhatia K, Sharp GB, Law MG, and Arthur Chen YM
- Subjects
- Adolescent, Adult, Female, Humans, Incidence, Male, Middle Aged, Risk Assessment, Taiwan epidemiology, Young Adult, Acquired Immunodeficiency Syndrome complications, Neoplasms epidemiology
- Abstract
Background: The aims of this study were to investigate the cancer incidence and risk in HIV/AIDS patients relative to the general population in Taiwan., Methods: Using Taiwan's National Health Insurance Research Database, 15,269 HIV/AIDS patients were identified between 1998 and 2009. Gender-specific incidence densities (IDs) of both AIDS-defining cancers (ADC) and non-AIDS-defining cancers (NADC) after HIV infection were calculated. Age-, sex-, and period-adjusted standardized incidence rates (SIRs) were obtained using 1.8 million people from the general population as controls., Results: A total of 1117 male and 165 female HIV/AIDS patients were diagnosed with cancer. Non-Hodgkin lymphoma (n = 196; ID = 328.79/100,000 person-years) and cervical cancer (n = 50; ID = 712.08/100,000 person-years) were the most common ADCs, whereas liver cancer (n = 125; ID = 184.52/100,000 person-years) and colon cancer (n = 11; ID = 156.66/100,000 person-years) were the most common NADCs in males and females, respectively. Period-adjusted gender-specific ADC and NADC rates decreased from more than 1500 cases/100,000 person-years to less than 500 cases/100,000 person-years (P < 0.001 for trend). SIRs of ADCs and NADCs also decreased. However, relative to the general population, increased SIRs were still seen for most cancers, many of which had an infectious etiology. The highest SIRs in ADCs and NADCs were seen in Kaposi sarcoma [SIR = 298.0, 95% confidence interval (CI): 258.16 to 343.85] and anal cancer (SIR = 19.10, 95% CI: 12.80 to 27.50)., Conclusion: This study showed that although the cancer incidence rates have significantly decreased in the highly active antiretroviral therapy era, HIV/AIDS patients were still at increased risk of ADCs and most NADCs. Cancer screening, especially for infection-related NADCs, should therefore be promoted.
- Published
- 2014
- Full Text
- View/download PDF
19. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.
- Author
-
Aka PV, Kuniholm MH, Pfeiffer RM, Wang AS, Tang W, Chen S, Astemborski J, Plankey M, Villacres MC, Peters MG, Desai S, Seaberg EC, Edlin BR, Strickler HD, Thomas DL, Prokunina-Olsson L, Sharp GB, and O'Brien TR
- Subjects
- Adult, Black or African American, Alleles, Cohort Studies, Female, Humans, Prospective Studies, Genetic Predisposition to Disease, Hepacivirus immunology, Hepacivirus isolation & purification, Hepatitis C immunology, Interleukins genetics
- Abstract
Interferon lambda 4 protein can be generated in IFNL4-ΔG carriers but not IFNL4-TT homozygotes. We studied 890 anti-hepatitis C virus (HCV)-positive participants in the Women's Interagency HIV Study. Among blacks (n = 555), HCV was more often cleared for those with genotype IFNL4-TT/TT (32.6%; odds ratio [OR], 3.59; P = 3.3 × 10(-5)) than IFNL4-TT/ΔG (11.3%; OR, 0.95; P = .86) or IFNL4-ΔG/ΔG (11.9%; referent). Pooling these data with published results in blacks (n = 1678), ORs were 3.84 (P = 8.6 × 10(-14)) for IFNL4-TT/TT and 1.44 (P = .03) IFNL4-TT/ΔG, and the area under the curve was 0.64 for IFNL4-ΔG genotype and 0.61 for rs12979860 (IL28B). IFNL4-ΔG is strongly associated with impaired spontaneous HCV clearance.
- Published
- 2014
- Full Text
- View/download PDF
20. Alcohol consumption trajectory patterns in adult women with HIV infection.
- Author
-
Cook RL, Zhu F, Belnap BH, Weber KM, Cole SR, Vlahov D, Cook JA, Hessol NA, Wilson TE, Plankey M, Howard AA, Sharp GB, Richardson JL, and Cohen MH
- Subjects
- Adult, Alcohol Drinking psychology, Alcoholism epidemiology, Alcoholism psychology, Depression epidemiology, Depression psychology, Female, Humans, Prospective Studies, Surveys and Questionnaires, Time Factors, United States epidemiology, Alcohol Drinking epidemiology, HIV Infections psychology
- Abstract
HIV-infected women with excessive alcohol consumption are at risk for adverse health outcomes, but little is known about their long-term drinking trajectories. This analysis included longitudinal data, obtained from 1996 to 2006, from 2,791 women with HIV from the Women's Interagency HIV Study. Among these women, the proportion in each of five distinct drinking trajectories was: continued heavy drinking (3 %), reduction from heavy to non-heavy drinking (4 %), increase from non-heavy to heavy drinking (8 %), continued non-heavy drinking (36 %), and continued non-drinking (49 %). Depressive symptoms, other substance use (crack/cocaine, marijuana, and tobacco), co-infection with hepatitis C virus (HCV), and heavy drinking prior to enrollment were associated with trajectories involving future heavy drinking. In conclusion, many women with HIV change their drinking patterns over time. Clinicians and those providing alcohol-related interventions might target those with depression, current use of tobacco or illicit drugs, HCV infection, or a previous history of drinking problems.
- Published
- 2013
- Full Text
- View/download PDF
21. A single-nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in plasma and hair among HIV-infected women.
- Author
-
Gandhi M, Greenblatt RM, Bacchetti P, Jin C, Huang Y, Anastos K, Cohen M, Dehovitz JA, Sharp GB, Gange SJ, Liu C, Hanson SC, and Aouizerat B
- Subjects
- Adult, Alkynes, Anti-HIV Agents administration & dosage, Benzoxazines administration & dosage, Cyclopropanes, Cytochrome P-450 CYP2B6, Female, HIV Infections drug therapy, Humans, Middle Aged, Young Adult, Anti-HIV Agents pharmacokinetics, Aryl Hydrocarbon Hydroxylases genetics, Benzoxazines pharmacokinetics, Hair chemistry, Oxidoreductases, N-Demethylating genetics, Plasma chemistry, Polymorphism, Single Nucleotide
- Abstract
Background: Efavirenz exhibits marked interindividual variability in plasma levels and toxicities. Prior pharmacogenetic studies usually measure exposure via single plasma levels, examine limited numbers of polymorphisms, and rarely model multiple contributors. We analyzed numerous genetic and nongenetic factors impacting short-term and long-term exposure in a large heterogeneous population of human immunodeficiency virus (HIV)-infected women., Methods: We performed 24-hour intensive pharmacokinetic studies in 111 women receiving efavirenz under actual-use conditions and calculated the area-under-the-concentration-time curve (AUC) to assess short-term exposure; the efavirenz concentration in hair was measured to estimate long-term exposure. A total of 182 single-nucleotide polymorphisms (SNPs) and 45 haplotypes in 9 genes were analyzed in relationship to exposure by use of multivariate models that included a number of nongenetic factors., Results: Efavirenz AUCs increased 1.26-fold per doubling of the alanine aminotransferase level and 1.23-fold with orange and/or orange juice consumption. Individuals with the CYP2B6 516TT genotype displayed 3.5-fold increases in AUCs and 3.2-fold increases in hair concentrations, compared with individuals with the TG/GG genotype. Another SNP in CYP2B6 (983TT) and a p-glycoprotein haplotype affected AUCs without substantially altering long-term exposure., Conclusions: This comprehensive pharmacogenomics study showed that individuals with the CYP2B6 516TT genotype displayed >3-fold increases in both short-term and long-term efavirenz exposure, signifying durable effects. Pharmacogenetic testing combined with monitoring of hair levels may improve efavirenz outcomes and reduce toxicities.
- Published
- 2012
- Full Text
- View/download PDF
22. Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children.
- Author
-
Asghar SJ, Milesi-Hallé A, Kaushik C, Glasier C, and Sharp GB
- Subjects
- Adolescent, Anti-Inflammatory Agents therapeutic use, Brain Edema complications, Calcium Channel Blockers therapeutic use, Calcium Channels genetics, Child, Cognition Disorders etiology, DNA genetics, Electroencephalography, Female, Functional Laterality, Gait Disorders, Neurologic etiology, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Methylprednisolone therapeutic use, Migraine with Aura complications, Migraine with Aura genetics, Neurologic Examination, Sodium-Potassium-Exchanging ATPase genetics, Verapamil therapeutic use, Brain Edema physiopathology, Migraine with Aura physiopathology
- Abstract
Three children with familial hemiplegic migraine presented with right-sided weakness, speech difficulty, altered mental status, and gait abnormalities. These persistent aura signs were accompanied by left-sided slowing and cerebral dysfunction, documented by electroencephalograms. Cranial magnetic resonance imaging revealed cortical edema restricted to the left cerebral hemisphere. Follow-up electroencephalogram and imaging studies produced normal results 1-4 months afterward. However, cognitive changes persisted. Genetic testing demonstrated variable results: one child manifested a CACNA1A mutation compatible with familial hemiplegic migraine type 1, whereas another demonstrated an ATP1A2 sequence alteration. No known mutations were evident in the third child, with minor head trauma thought to precipitate the familial hemiplegic migraine. These findings demonstrate the variable clinical and genetic heterogeneity of childhood familial hemiplegic migraine., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
23. Dynamics of the HIV epidemic in southern China: sexual and drug-using behaviours among female sex workers and male clients in Yunnan.
- Author
-
Xu JJ, Smith MK, Chu J, Ding GW, Chang DF, Sharp GB, Qian HZ, Lu L, Bi AM, and Wang N
- Subjects
- Adolescent, Adult, Aged, China epidemiology, Condoms, Cross-Sectional Studies, Female, Humans, Logistic Models, Male, Middle Aged, Needle Sharing, Prevalence, Risk-Taking, Surveys and Questionnaires, Drug Users statistics & numerical data, Epidemics, HIV Infections epidemiology, Sex Work statistics & numerical data, Sexual Behavior statistics & numerical data
- Abstract
To examine the HIV/sexually transmitted infection (STI)-related risk behaviours among community-based female sex workers (FSWs) and their clients in Yunnan Province, China, we performed a cross-sectional study of 705 FSWs and 100 male clients. We found that HIV seroprevalence among FSWs was 13.0% and the most prevalent STI was herpes simplex virus type 2 (HSV-2) (71.1%), followed by Chlamydia trachomatis (18.1%) and syphilis (8.8%). The 20% of FSWs who reported injection drug use also reported needle-sharing behaviours in the last three months. Drug-using FSWs had substantially higher HIV and HSV-2 prevalence, serviced more clients and had a longer history of sex work than non-using FSWs. In total, 57.0% of male clients did not consistently use condoms with FSWs, 2.0% reported illicit drug use and 17.0% had STI symptoms in the last year. The dual risk behaviours of drug-using FSWs and clients place them at greater risk of HIV infection. Intervention programmes must adopt comprehensive methods.
- Published
- 2012
- Full Text
- View/download PDF
24. Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.
- Author
-
Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, and Peters MG
- Subjects
- Adult, Antiretroviral Therapy, Highly Active, Aspartate Aminotransferases blood, Female, Follow-Up Studies, HIV Infections complications, HIV Infections drug therapy, Hepatitis C complications, Humans, Liver Cirrhosis blood, Liver Cirrhosis complications, Longitudinal Studies, Middle Aged, Platelet Count, Proportional Hazards Models, Risk Factors, Viral Load, HIV Infections mortality, Hepatitis C mortality, Liver Cirrhosis mortality
- Abstract
Objective: Co-infection with hepatitis C virus (HCV) is a major cause of morbidity and mortality in HIV-infected individuals. However, predictors of mortality are poorly defined and most studies have focused predominantly on co-infection in men. We evaluated whether two indirect markers of hepatic fibrosis, aspartate aminotransferase-to-platelet ratio index (APRI) and FIB-4 scores, were predictive of mortality in a well defined longitudinal cohort of HCV/HIV-co-infected women on HAART., Methods: HCV/HIV-co-infected women on antiretroviral therapy enrolled in Women's Interagency HIV Study (WIHS), a National Institutes of Health-funded prospective, multicenter, cohort study of women with and at risk for HIV infection were included. Using Cox regression analysis, associations between APRI and FIB-4 with all-cause mortality were assessed., Results: Four hundred and fifty HCV/HIV-co-infected women, of whom 191 women died, had a median follow-up of 6.6 years and 5739 WIHS visits. Compared with women with low APRI or FIB-4 levels, severe fibrosis was significantly associated with an increased risk of all-cause mortality {APRI: hazard ratio 2.78 [95% confidence interval (CI) 1.87, 4.12]; FIB-4: hazard ratio 2.58 (95% CI 1.68, 3.95)}. Crude death rates per 1000 patient-years increased with increasing liver fibrosis: 34.8 for mild, 51.3 for moderate and 167.9 for severe fibrosis as measured by FIB-4. Importantly, both APRI and FIB-4 increased during the 5 years prior to death for all women: the slope of increase was greater for women dying a liver-related death compared with nonliver-related death., Conclusion: Both APRI and FIB-4 are independently associated with all-cause mortality in HCV/HIV-co-infected women and may have clinical prognostic utility among women with HIV and HCV.
- Published
- 2012
- Full Text
- View/download PDF
25. Associations of ionizing radiation and breast cancer-related serum hormone and growth factor levels in cancer-free female A-bomb survivors.
- Author
-
Grant EJ, Neriishi K, Cologne J, Eguchi H, Hayashi T, Geyer S, Izumi S, Nishi N, Land C, Stevens RG, Sharp GB, and Nakachi K
- Subjects
- Adolescent, Adult, Biomarkers blood, Breast Neoplasms physiopathology, Child, Child, Preschool, Dose-Response Relationship, Radiation, Environmental Exposure adverse effects, Female, Humans, Infant, Menopause blood, Middle Aged, Neoplasms, Radiation-Induced physiopathology, Risk, Young Adult, Breast Neoplasms blood, Hormones blood, Intercellular Signaling Peptides and Proteins blood, Neoplasms, Radiation-Induced blood, Nuclear Weapons, Survivors statistics & numerical data
- Abstract
Levels of exposure to ionizing radiation are increasing for women worldwide due to the widespread use of CT and other radiologic diagnostic modalities. Exposure to ionizing radiation as well as increased levels of estradiol and other sex hormones are acknowledged breast cancer risk factors, but the effects of whole-body radiation on serum hormone levels in cancer-free women are unknown. This study examined whether ionizing radiation exposure is associated with levels of serum hormones and other markers that may mediate radiation-associated breast cancer risk. Serum samples were measured from cancer-free women who attended biennial health examinations with a wide range of past radiation exposure levels (N = 412, ages 26-79). The women were selected as controls for separate case-control studies from a cohort of A-bomb survivors. Outcome measures included serum levels of total estradiol, bioavailable estradiol, testosterone, progesterone, prolactin, insulin-like growth factor-1 (IGF1), insulin-like growth factor-binding protein 3 (IGFBP-3), and ferritin. Relationships were assessed using repeated-measures regression models fitted with generalized estimating equations. Geometric mean serum levels of total estradiol and bioavailable estradiol increased with 1 Gy of radiation dose among samples collected from postmenopausal women (17%(1Gy), 95% CI: 1%-36% and 21%(1Gy), 95% CI: 4%-40%, respectively), while they decreased in samples collected from premenopausal women (-11%(1Gy), 95% CI: -20%-1% and -12%(1Gy), 95% CI: -20%- -2%, respectively). Interactions by menopausal status were significant (P = 0.003 and P < 0.001, respectively). Testosterone levels increased with radiation dose in postmenopausal samples (30.0%(1Gy), 95% CI: 13%-49%) while they marginally decreased in premenopausal samples (-10%(1Gy), 95% CI: -19%-0%) and the interaction by menopausal status was significant (P < 0.001). Serum levels of IGF1 increased linearly with radiation dose (11%(1Gy), 95% CI: 2%-18%) and there was a significant interaction by menopausal status (P = 0.014). Radiation-associated changes in serum levels of estradiol, bioavailable estradiol, testosterone and IGF1 were modified by menopausal status at the time of collection. No associations with radiation were observed in serum levels of progesterone, prolactin, IGFBP-3 or ferritin.
- Published
- 2011
- Full Text
- View/download PDF
26. Seroincidence of 2009 H1N1 infection in HIV-infected and HIV-uninfected women prior to vaccine availability.
- Author
-
Althoff KN, Eichelberger M, Gange SJ, Sharp GB, Gao J, Glesby MJ, Young M, Greenblatt RM, French AL, Villacres MC, and Minkoff H
- Subjects
- Adult, Aged, CD4 Lymphocyte Count, Female, HIV Infections complications, HIV Infections immunology, Humans, Influenza, Human immunology, Middle Aged, Pandemics, Risk Factors, HIV Infections epidemiology, HIV-1 immunology, Influenza A Virus, H1N1 Subtype immunology, Influenza, Human epidemiology
- Abstract
The 2009 H1N1 pandemic was a unique opportunity to investigate differences in influenza infection using serology by HIV status. Using serial serum specimens collected from 1 April to 30 September 2009 and the prior 2 years from Women's Interagency HIV study participants, there was no difference in serologic evidence of 2009 H1N1 infection among HIV-infected women with a CD4 cell count at least 350 cells/μl compared with HIV-uninfected women. Owing to evidence showing a greater risk of influenza-related complications, HIV-infected individuals should continue to be a priority group for vaccination.
- Published
- 2011
- Full Text
- View/download PDF
27. Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapy.
- Author
-
Gandhi M, Ameli N, Bacchetti P, Anastos K, Gange SJ, Minkoff H, Young M, Milam J, Cohen MH, Sharp GB, Huang Y, and Greenblatt RM
- Subjects
- Adult, Aged, Anti-HIV Agents pharmacokinetics, Atazanavir Sulfate, Drug Monitoring methods, Female, Humans, Longitudinal Studies, Medication Adherence, Middle Aged, Models, Statistical, Oligopeptides pharmacokinetics, Pyridines pharmacokinetics, Treatment Outcome, Anti-HIV Agents administration & dosage, Antiretroviral Therapy, Highly Active, HIV Infections drug therapy, Hair chemistry, Oligopeptides administration & dosage, Pyridines administration & dosage
- Abstract
Background: Adequate exposure to antiretrovirals is important to maintain durable responses, but methods to assess exposure (eg, querying adherence and single plasma drug level measurements) are limited. Hair concentrations of antiretrovirals can integrate adherence and pharmacokinetics into a single assay., Methods: Small hair samples were collected from participants in the Women's Interagency HIV Study (WIHS), a large cohort of human immunodeficiency virus (HIV)-infected (and at-risk noninfected) women. From 2003 through 2008, we analyzed atazanavir hair concentrations longitudinally for women reporting receipt of atazanavir-based therapy. Multivariate random effects logistic regression models for repeated measures were used to estimate the association of hair drug levels with the primary outcome of virologic suppression (HIV RNA level, <80 copies/mL)., Results: 424 WIHS participants (51% African-American, 31% Hispanic) contributed 1443 person-visits to the analysis. After adjusting for age, race, treatment experience, pretreatment viral load, CD4 count and AIDS status, and self-reported adherence, hair levels were the strongest predictor of suppression. Categorized hair antiretroviral levels revealed a monotonic relationship to suppression; women with atazanavir levels in the highest quintile had odds ratios (ORs) of 59.8 (95% confidence ratio, 29.0-123.2) for virologic suppression. Hair atazanavir concentrations were even more strongly associated with resuppression of viral loads in subgroups in which there had been previous lapses in adherence (OR, 210.2 [95% CI, 46.0-961.1]), low hair levels (OR, 132.8 [95% CI, 26.5-666.0]), or detectable viremia (OR, 400.7 [95% CI, 52.3-3069.7])., Conclusions: Antiretroviral hair levels surpassed any other predictor of virologic outcomes to HIV treatment in a large cohort. Low antiretroviral exposure in hair may trigger interventions prior to failure or herald virologic failure in settings where measurement of viral loads is unavailable. Monitoring hair antiretroviral concentrations may be useful for prolonging regimen durability.
- Published
- 2011
- Full Text
- View/download PDF
28. Nerve root enhancement on spinal MRI in pediatric Guillain-Barré syndrome.
- Author
-
Mulkey SB, Glasier CM, El-Nabbout B, Walters WD, Ionita C, McCarthy MH, Sharp GB, and Shbarou RM
- Subjects
- Adolescent, Child, Child, Preschool, Female, Humans, Lumbar Vertebrae, Magnetic Resonance Imaging, Male, Retrospective Studies, Young Adult, Guillain-Barre Syndrome pathology, Spinal Nerve Roots pathology
- Abstract
Guillain-Barré syndrome diagnosis is based on clinical presentation and supportive diagnostic testing. In its early stage, no single, reliable diagnostic test is available. However, a finding of nerve root enhancement on spinal magnetic resonance imaging may be useful. We evaluated the frequency of nerve root enhancement on spinal magnetic resonance imaging in children with Guillain-Barré syndrome. At a single tertiary pediatric center, we conducted a retrospective chart review of children with Guillain-Barré syndrome who had complete spinal or lumbosacral spinal magnetic resonance imaging with gadolinium administration from January 2002-January 2009. Twenty-four consecutive patients were identified. Spinal nerve root enhancement with gadolinium was present in 92% (22/24) of children with Guillain-Barré syndrome on initial spinal magnetic resonance imaging (95% confidence interval, 0.745-0.978). This finding increased to 100% of patients, after two patients underwent repeat spinal magnetic resonance imaging that did reveal nerve root enhancement. Patterns of enhancement were variable, but involved the thoracolumbar nerve roots in all patients. Enhancement of nerve roots with gadolinium on initial spinal magnetic resonance imaging was frequently present in these children with Guillain-Barré syndrome. Spinal magnetic resonance imaging is a sensitive diagnostic test and should be considered an additional diagnostic tool in select cases., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
29. Mobility, risk behavior and HIV/STI rates among female sex workers in Kaiyuan City, Yunnan Province, China.
- Author
-
Wang H, Chen RY, Sharp GB, Brown K, Smith K, Ding G, Jin X, Xu J, Dong R, and Wang N
- Subjects
- Adolescent, Adult, China epidemiology, Female, HIV Infections transmission, Humans, Incidence, Longitudinal Studies, Middle Aged, Prevalence, Sexually Transmitted Diseases transmission, Young Adult, HIV Infections epidemiology, Risk-Taking, Sex Work, Sexually Transmitted Diseases epidemiology
- Abstract
Background: The mobility of female sex workers (FSWs) is a factor in the geographic spread of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs). This study describes FSW mobility patterns in a high risk area of China to identify factors associated with increased mobility, and to study the incidence and prevalence of HIV/STIs in this group., Methods: 270 FSWs recruited from a baseline cross-sectional study were invited to participate in a one-year monthly follow-up cohort study in Kaiyuan City, Yunnan Province, China from 2006 to 2007. Laboratory tests were conducted for HIV/STIs at baseline, 6 and 12 months., Results: A total of 117 (43.3%) FSWs moved to another city during the year. Risk factors for increased mobility included being from another city within Yunnan (adjusted hazard ratio [AHR] 1.67, 95% confidence interval [CI] 1.09-2.56), being from outside Yunnan (AHR 1.58, 95% CI 1.04-2.54), and working in lower risk entertainment establishments (AHR 1.55, 95% CI 1.03-2.35). HIV-positive subjects, drug users and FSWs in higher risk venue were less likely to change residence, less likely to use condoms with clients, and earned less per client, but had more working locations and more clients each month., Conclusions: The least mobile FSWs were from Kaiyuan, worked in higher risk venues, were more likely to use drugs and be HIV-infected. Because FSWs characteristics differ according to the venue at which they work, future prevention work should tailor programs according to venue with a particular focus on FSWs in higher risk venues.
- Published
- 2010
- Full Text
- View/download PDF
30. Application of the BED capture enzyme immunoassay for HIV incidence estimation among female sex workers in Kaiyuan City, China, 2006-2007.
- Author
-
Xu J, Wang H, Jiang Y, Ding G, Jia M, Wang G, Chu J, Smith K, Sharp GB, Chen RY, Jin X, Dong R, Han X, Shang H, and Wang N
- Subjects
- Adult, China epidemiology, Cohort Studies, Cross-Sectional Studies, Female, HIV Infections virology, Humans, Immunoenzyme Techniques methods, Immunoglobulin G blood, Incidence, Young Adult, HIV Antibodies blood, HIV Infections epidemiology, HIV-1 immunology, Sex Work
- Abstract
Objective: To estimate HIV incidence among female sex workers (FSWs) by serial cross-sectional surveys and IgG-capture BED-enzyme immunoassay (BED-CEIA)., Methods: We conducted three cross-sectional surveys, 6 months apart, among all consenting FSWs in Kaiyuan City, China. HIV antibody-positive samples were also tested by BED-CEIA., Results: Among 1412 unique participants, 475 tested HIV-negative and attended >1 survey (longitudinal cohort). Compared to 786 HIV-negative FSWs who only participated once, the longitudinal cohort reported more illicit drug use (10.9% vs. 7.4%, p=0.03), injected drugs more often in the previous 3 months (8.8% vs. 5.3%, p=0.02), and had more positive urine opiate tests (13.7% vs. 8.9%, p=0.008). Four participants in the longitudinal cohort seroconverted over the year, with an overall incidence of 1.1/100 person-years (95% confidence interval (CI) 0.3-2.8). Crude BED-CEIA incidence was 3.4/100 person-years (95% CI 2.3-4.4) with adjusted rates similar to the cohort incidence: McDougal, 1.5/100 person-years (95% CI 1.0-2.0); Hargrove, 1.6/100 person-years (95% CI 1.1-2.1). The BED-CEIA false-positive rate was 4.4% (10/229) among samples from FSWs known to be infected > or =365 days., Conclusions: Although limited by power, this study provides additional data towards validating BED-CEIA in China. If confirmed by other studies, BED-CEIA will be a useful tool to estimate HIV incidence rates and trends., (Copyright 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
31. Disparities in hospital outcomes for injured people with epilepsy/seizures.
- Author
-
Bowman SM, Aitken ME, and Sharp GB
- Subjects
- Accidental Falls mortality, Accidental Falls statistics & numerical data, Adult, Aged, Brain Injuries rehabilitation, Brain Injuries therapy, Child, Comorbidity, Female, Health Care Surveys, Hospital Mortality, Humans, Logistic Models, Male, Middle Aged, Risk Factors, Treatment Outcome, United States epidemiology, Wounds and Injuries epidemiology, Wounds and Injuries mortality, Epilepsy epidemiology, Healthcare Disparities statistics & numerical data, Hospitalization statistics & numerical data, Outcome Assessment, Health Care statistics & numerical data, Seizures epidemiology, Wounds and Injuries therapy
- Abstract
Purpose: Controlling for injury and patient characteristics, one would expect comparable in-hospital outcomes for injured patients with and without epilepsy. The historical stigma associated with epilepsy is well-documented, yet potential disparities in injury care for people with epilepsy/seizures have not been examined. We compared in-hospital outcomes of injured patients with epilepsy/seizures with patients without epilepsy/seizures and tested the hypothesis that injured people with epilepsy have worse outcomes., Methods: Existing data were analyzed from the Nationwide Inpatient Sample-the largest, longitudinal, all-payer inpatient care database in the United States. Injured patients of all ages were included. Multivariable logistic regression was used to control for patient and hospital characteristics., Main Outcome Measure: In-hospital mortality., Results: When controlling for patient and injury characteristics, our results show that people with epilepsy/seizures were more likely to die in-hospital than people without epilepsy [odds ratio (OR) 1.17, p < 0.001]. People with epilepsy were significantly more likely to have a traumatic brain injury diagnosis than similar individuals without epilepsy (unintentional injuries OR 2.81, p < 0.001; interpersonal violence OR 6.0, p < 0.001). By mechanism of injury, significantly increased risk of death was observed for injuries from falls (OR 1.21, p < 0.001), other transport injuries (OR 2.04, p = 0.01), struck by/against (OR 1.85, p = 0.02), and suffocation (OR 10.93, p = 0.009). People with epilepsy/seizures receiving firearm injuries were less likely to die in-hospital (OR 0.25, p < 0.001)., Discussion: Disparities in hospital outcomes for people with epilepsy deserve further attention. Identifying the underlying causes of these disparities will allow for the development of targeted prevention interventions.
- Published
- 2010
- Full Text
- View/download PDF
32. Disparities in injury death location for people with epilepsy/seizures.
- Author
-
Bowman SM, Aitken ME, and Sharp GB
- Subjects
- Adolescent, Adult, Age Factors, Cause of Death, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, National Center for Health Statistics, U.S., Population Surveillance, Retrospective Studies, Risk Factors, Sex Factors, Statistics, Nonparametric, United States epidemiology, Young Adult, Demography, Epilepsy epidemiology, Epilepsy mortality
- Abstract
Objective: Wide variation has been reported in the proportion of injury deaths occurring during the prehospital phase. Potential disparities in where injured people with epilepsy and seizure disorders die have not been examined. We compared location of death between injured patients with epilepsy and seizure disorders and similar patients without epilepsy/seizures and tested the hypothesis that injured people with epilepsy/seizures are more likely to die outside of a hospital or health care setting., Methods: U.S. vital statistics (mortality) data from the multiple cause of death files of the National Center for Health Statistics were analyzed. Patients less than 65 years of age at death who had injury as the underlying cause of death were included. Multinomial logistic regression was used to assess location of death, controlling for patient and injury characteristics., Results: Controlling for potential confounders, people with epilepsy/seizures were more likely to die at home from unintentional injuries (relative risk ratio [RRR]=1.51, P<0.001) and less likely to die in public places (RRR=0.27, P<0.001). People with epilepsy/seizures were less likely to die at home or in public places from suicide, but significantly more likely to die at home from homicide (RRR=2.29, P<0.001). By mechanism of injury, people with epilepsy/seizures were more likely to die at home from drowning (RRR=2.35, P<0.001)., Discussion: Disparities in where injured people with epilepsy/seizures die deserve further attention. Identifying the underlying causes of these disparities will allow for the development of targeted prevention interventions., ((c) 2009 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
33. Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006.
- Author
-
Cook RL, Zhu F, Belnap BH, Weber K, Cook JA, Vlahov D, Wilson TE, Hessol NA, Plankey M, Howard AA, Cole SR, Sharp GB, Richardson JL, and Cohen MH
- Subjects
- Adult, Antiretroviral Therapy, Highly Active, Comorbidity, Female, HIV Infections drug therapy, Humans, Longitudinal Studies, Multivariate Analysis, Substance-Related Disorders epidemiology, United States epidemiology, Alcohol Drinking epidemiology, HIV Infections epidemiology
- Abstract
Hazardous alcohol consumption among women with human immunodeficiency virus (HIV) infection is associated with several adverse health and behavioral outcomes, but the proportion of HIV-positive women who engage in hazardous drinking over time is unclear. The authors sought to determine rates of hazardous alcohol consumption among these women over time and to identify factors associated with this behavior. Subjects were 2,770 HIV-positive women recruited from 6 US cities who participated in semiannual follow-up visits in the Women's Interagency HIV Study from 1995 to 2006. Hazardous alcohol consumption was defined as exceeding daily (> or =4 drinks) or weekly (>7 drinks) consumption recommendations. Over the 11-year follow-up period, 14%-24% of the women reported past-year hazardous drinking, with a slight decrease in hazardous drinking over time. Women were significantly more likely to report hazardous drinking if they were unemployed, were not high school graduates, had been enrolled in the original cohort (1994-1995), had a CD4 cell count of 200-500 cells/mL, were hepatitis C-seropositive, or had symptoms of depression. Approximately 1 in 5 of the women met criteria for hazardous drinking. Interventions to identify and address hazardous drinking among HIV-positive women are urgently needed.
- Published
- 2009
- Full Text
- View/download PDF
34. Prevalence and predictors of HIV infection among female sex workers in Kaiyuan City, Yunnan Province, China.
- Author
-
Wang H, Chen RY, Ding G, Ma Y, Ma J, Jiao JH, Wu Z, Sharp GB, and Wang N
- Subjects
- Adolescent, Adult, China epidemiology, Cross-Sectional Studies, Female, HIV-1, Humans, Male, Middle Aged, Prevalence, Risk Factors, Sexual Behavior, Substance-Related Disorders epidemiology, Unsafe Sex, Young Adult, HIV Infections epidemiology, HIV Infections prevention & control, HIV Infections transmission, Sex Work, Sexually Transmitted Diseases epidemiology, Sexually Transmitted Diseases prevention & control, Sexually Transmitted Diseases transmission, Substance-Related Disorders complications
- Abstract
Background: Sexual transmission is the fastest growing route of HIV transmission in China. We undertook this study to describe the risk factors for HIV infection in female sex workers (FSWs), and to determine the commercial sex venues where FSWs are most at risk of being infected with or infecting others with HIV., Methods: This was a cross-sectional study of 737 FSWs in Kaiyuan City, Yunnan Province in southern China, which took place from March to May 2006., Results: The overall HIV prevalence was 10.3%, but prevalence varied with sex venue with 25.8% of FSWs working on the streets being HIV-positive and none of the FSWs working in nightclubs. Adjusted odds ratios (OR) of HIV infection were 9.1 (95% confidence interval (CI) 4.67-17.55) for injection drug use, 3.3 (95% CI 1.46-7.37) for non-injection illegal drug use, 2.7 (95% CI 1.25-5.93) for duration of sex work > or = 5 years, 2.2 (95% CI 1.05-4.70) for infection with herpes simplex virus type 2, and 2.0 (95% CI 1.12-3.47) for working at a higher risk entertainment venue. Although condom use was not a significant risk factor in the overall model, FSWs in lower risk venues who reported consistent use with clients had a 70% reduction in HIV infections (OR 0.30, 95% CI 0.12-0.90)., Conclusions: Illegal drug use, particularly with injection drugs, is the single greatest risk factor for HIV infection among FSWs in Kaiyuan City, China. FSWs working on the street or in temporary sub-lets, beauty salons, or saunas are at particularly high risk for transmitting and being infected with HIV. HIV prevention efforts among FSWs should target illegal drug users and these other subgroups.
- Published
- 2009
- Full Text
- View/download PDF
35. Prevalence and predictors of herpes simplex virus type 2 infection among female sex workers in Yunnan Province, China.
- Author
-
Wang H, Wang N, Chen RY, Sharp GB, Ma Y, Wang G, Ding G, and Wu Z
- Subjects
- Adolescent, Adult, Antibodies, Viral blood, China epidemiology, Cross-Sectional Studies, Female, Herpes Simplex diagnosis, Humans, Middle Aged, Multivariate Analysis, Prevalence, Risk Factors, Risk-Taking, Sexually Transmitted Diseases diagnosis, Sexually Transmitted Diseases epidemiology, Sexually Transmitted Diseases etiology, Sexually Transmitted Diseases transmission, Young Adult, Herpes Simplex epidemiology, Herpesvirus 2, Human immunology, Sex Work
- Abstract
The objective of this study was to determine the seroprevalence of herpes simplex virus type 2 (HSV-2), and to evaluate the relationship between HSV-2 infection and sociodemographic factors and the sexual practices of female sex workers (FSWs) in Kaiyuan city, Yunnan Province, China. This cross-sectional study involved 737 FSWs and was carried out from March to May 2006 with confidential interviews and laboratory tests for HSV-2 and other sexually transmitted infections (STI). HSV-2 was the most common STI (68%), followed by Chlamydia trachomatis (26%), Trichomonas vaginalis (11%), Neisseria gonorrhoeae (8%) and syphilis (7%). Prevalence of HIV-1 was 10.3%. Adjusted odds ratios of HSV-2 seroprevalence were 2.6 (95% CI [confidence interval]: 1.30-5.38) for HIV-1 infection, 2.0 (95% CI: 1.33-3.16) for vaginal douching, 2.0 (95% CI: 0.45-0.86) for condom breaking or falling off during sexual intercourse with the client in the previous week, 1.8 (95% CI: 1.07-3.18) for > or =5 years of commercial sex work, 1.6 (95% CI: 1.08-2.33) for > or =5 clients in the previous week, 0.6 (95% CI: 0.45-0.86) for > or =9 years of education. This study identifies a very high prevalence of HSV-2 infections among FSWs in Yunnan Province, with only a few who reported a prior history of genital herpes. HSV-2 serological screening and suppressive therapy should be considered for study populations. Education on the importance of diagnosis, treatment and prevention may help control the spread of HSV-2 infection.
- Published
- 2008
- Full Text
- View/download PDF
36. Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
- Author
-
Liu C, Lerch V, Weber K, Schneider MF, Sharp GB, Gorapaju L, Sharma A, Levine A, Gandhi M, and Merenstein D
- Subjects
- Adult, Antiretroviral Therapy, Highly Active psychology, Female, HIV Infections epidemiology, HIV Infections psychology, Humans, Middle Aged, Multivariate Analysis, Quality of Life, Social Support, Women's Health, Antiretroviral Therapy, Highly Active statistics & numerical data, Complementary Therapies statistics & numerical data, HIV Infections drug therapy, Health Knowledge, Attitudes, Practice, Patient Compliance statistics & numerical data
- Published
- 2007
- Full Text
- View/download PDF
37. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.
- Author
-
French AL, Operskalski E, Peters M, Strickler HD, Tien PC, Sharp GB, Glesby MJ, Young M, Augenbraun M, Seaberg E, and Kovacs A
- Subjects
- Adult, Cohort Studies, Female, HIV Infections epidemiology, Hepacivirus isolation & purification, Hepatitis C epidemiology, Humans, Prevalence, Prospective Studies, United States epidemiology, Viral Load, HIV Infections complications, Hepatitis B Antibodies blood, Hepatitis B Core Antigens analysis, Hepatitis B Core Antigens immunology, Hepatitis C complications
- Abstract
To characterize predictors of isolated hepatitis B core antibody (anti-HBc) among human immunodeficiency virus (HIV)-infected and HIV-uninfected women, we compared 702 women with anti-HBc and hepatitis B surface antibody (anti-HBs) with 490 women with isolated anti-HBc (1.8% of whom had detectable hepatitis B virus [HBV] DNA). Factors independently associated with isolated anti-HBc without viremia were detectable hepatitis C virus (HCV) RNA, HIV positivity, history of injection drug use, >10 lifetime sex partners, and HIV RNA level >100,000 copies/mL. Anti-HBs levels were lower among anti-HCV-positive women. Isolated anti-HBc was rarely explained by occult HBV in this cohort but may be explained by the influence of viral coinfections on anti-HBs level or durability.
- Published
- 2007
- Full Text
- View/download PDF
38. Lack of association between acute exposure to ionizing radiation and liver cirrhosis.
- Author
-
Sharp GB, Mizuno T, Fukuhara T, and Tokuoka S
- Subjects
- Body Burden, Cohort Studies, Comorbidity, Cross-Sectional Studies, Female, Hepatitis B mortality, Hepatitis C mortality, Humans, Incidence, Japan epidemiology, Male, Radiation Dosage, Relative Biological Effectiveness, Retrospective Studies, Risk Factors, Smoking epidemiology, Statistics as Topic, Environmental Exposure statistics & numerical data, Liver Cirrhosis mortality, Nuclear Warfare statistics & numerical data, Radiation Injuries mortality, Radiation, Ionizing, Risk Assessment methods, Survivors statistics & numerical data
- Abstract
Purpose: Although previous studies have shown significantly increased risks of liver cirrhosis and chronic liver disease for acute radiation exposure among survivors of the atomic bombings of Hiroshima and Nagasaki, Japan, these studies have not taken into account hepatitis B virus (HBV) infections. Because HBV is associated with both A-bomb radiation and liver cirrhosis, our goal was to investigate the relationship of acute ionizing radiation to liver cirrhosis adjusting for HBV, co-occurring primary liver cancer (PLC), and other potential confounders., Materials and Methods: Using a cross-sectional design and pathology review of a cohort of Japanese atomic-bomb survivors, we found that 213 of 335 (63.6%) subjects with PLC and 55 of 776 (7.1%) subjects without PLC had cirrhosis., Results: We found no association between acute exposure to A-bomb radiation and liver cirrhosis. The adjusted odds ratio of cirrhosis per Sv liver irradiation was 0.59 (95% confidence interval: 0.27 - 1.27). Cirrhosis risks for the highest tertile of radiation exposure (mean exposure 0.7 Sv) were also not elevated (0.8, 0.26 - 2.12 and 0.2, 0.03 - 0.98 among subjects with and without PLC., Conclusions: Acute exposure to liver irradiation does not increase risks of liver cirrhosis, regardless of PLC status.
- Published
- 2006
- Full Text
- View/download PDF
39. Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols.
- Author
-
Gandhi M, Ameli N, Bacchetti P, Sharp GB, French AL, Young M, Gange SJ, Anastos K, Holman S, Levine A, and Greenblatt RM
- Subjects
- Clinical Protocols, Cohort Studies, Female, Humans, HIV Infections drug therapy, Patient Selection, Randomized Controlled Trials as Topic methods
- Abstract
Objective: Applicability of randomized controlled clinical trial (RCT) results to 'real world' situations is dependent on the comparability of trial participants to general patient populations. A full disclosure of criteria employed for trial enrollment is necessary for clinicians to assess generalizability. We sought to assess both the impact on generalizability and the disclosure rate of enrollment criteria for 32 major HIV RCTs in the AIDS Clinical Trial Group (ACTG) and Community Programs for Clinical Research on AIDS (CPCRA) trial networks., Design and Methods: Eligibility criteria were compared in complete protocols to criteria listed in publications from these 32 NIH-funded HIV RCTs. We then applied these criteria to the Women's Interagency HIV Study (WIHS), the largest cohort study of HIV-infected women in the US., Results: When applied to WIHS, eligibility criteria from protocols excluded 0-67.6% (median 42%) of WIHS participants (50.6% excluded from ACTG trials). Eligibility criteria in publications excluded 0-62% (median 19.6%) of WIHS (21.2% excluded from ACTG trials). The number of women in WIHS seemingly ineligible for trial participation per enrollment criteria listed in publications averaged only 60% of those actually excluded based on the protocols., Conclusions: We found that HIV RCT eligibility criteria excluded a large proportion of a representative cohort of HIV-infected women from trial participation. Furthermore, trial publications are not fully reflective of protocols in terms of disclosing eligibility criteria. Standardization and full disclosure of trial methodology will allow clinicians and researchers to more fully assess the generalizability of findings to their patient populations.
- Published
- 2005
- Full Text
- View/download PDF
40. Relationship of hepatocellular carcinoma to soya food consumption: a cohort-based, case-control study in Japan.
- Author
-
Sharp GB, Lagarde F, Mizuno T, Sauvaget C, Fukuhara T, Allen N, Suzuki G, and Tokuoka S
- Subjects
- Carcinoma, Hepatocellular epidemiology, Carcinoma, Hepatocellular etiology, Case-Control Studies, Cohort Studies, Feeding Behavior, Hepacivirus isolation & purification, Hepatitis B complications, Hepatitis B epidemiology, Hepatitis B virus isolation & purification, Hepatitis C complications, Hepatitis C epidemiology, Humans, Japan, Liver Neoplasms epidemiology, Liver Neoplasms etiology, Risk Factors, Carcinoma, Hepatocellular diet therapy, Hepatitis B diet therapy, Hepatitis C diet therapy, Liver Neoplasms diet therapy, Soy Foods
- Abstract
To determine if the risk of hepatocellular carcinoma (HCC) is reduced by consumption of soya foods, we conducted a case-control study within a cohort of Japanese A-bomb survivors. We compared the prediagnosis consumption of isoflavone-rich miso soup and tofu to HCC risk, adjusting for hepatitis B (HBV) and C (HCV) viral infections, the major HCC risk factors in this population. The study included 176 pathologist-confirmed cases of HCC diagnosed in 1964-1988 and 560 controls who died of diseases other than liver cancer. We examined dietary information collected at least 2 years before diagnosis or death and tissue-based measures of viral hepatitis. Using logistic regression, crude ORs were 0.5 (95% CI 0.29-0.95) and 0.5 (95% CI 0.20-0.99) for high vs. low miso soup and tofu intake, respectively. Adjusting for year of birth, sex, HBV, HCV and other factors, the OR for miso soup was unchanged at 0.5 (95% CI 0.14-1.55), and miso results were similar when ORs were recalculated separately for earlier and later birth cohorts to assess consistency of results. The adjusted OR for tofu was 0.9 (95% CI 0.20-3.51). We also found a statistically significant (p < 0.0001) interaction between sex and HCV, with risk of HCC being substantially higher for women. We conclude that consumption of miso soup and other soya foods may reduce HCC risk., (Copyright 2005 Wiley-Liss, Inc)
- Published
- 2005
- Full Text
- View/download PDF
41. Joint effects of radiation and smoking on lung cancer risk among Atomic bomb survivors.
- Author
-
Pierce DA, Sharp GB, and Mabuchi K
- Subjects
- Comorbidity, Confounding Factors, Epidemiologic, Humans, Japan epidemiology, Prevalence, Radiation Dosage, Risk Factors, Neoplasms, Radiation-Induced mortality, Nuclear Warfare statistics & numerical data, Radiation Monitoring methods, Radiation Protection methods, Risk Assessment methods, Smoking epidemiology, Survivors statistics & numerical data
- Published
- 2005
42. Improving the efficiency of nested case-control studies of interaction by selecting controls using counter matching on exposure.
- Author
-
Cologne JB, Sharp GB, Neriishi K, Verkasalo PK, Land CE, and Nakachi K
- Subjects
- Breast Neoplasms epidemiology, Cohort Studies, Confounding Factors, Epidemiologic, Estradiol blood, Female, Humans, Matched-Pair Analysis, Models, Statistical, Neoplasms, Radiation-Induced epidemiology, Random Allocation, Risk Factors, Case-Control Studies
- Abstract
Background: Studies of the effect of exposure to a risk factor measured in an entire cohort may be augmented by nested case-control subsets to investigate confounding or effect modification by additional factors not practically assessed on all cohort members. We compared three control-selection strategies-matching on exposure, counter matching on exposure, and random sampling-to determine which was most efficient in a situation where exposure is a known, continuous variable and high doses are rare., Methods: We estimated the power to detect interaction using four control-to-case ratios (1:1, 2:1, 4:1, and 8:1) in a planned case-control study of the joint effect of atomic bomb radiation exposure and serum oestradiol levels on breast cancer. Radiation dose is measured in the entire cohort, but because neither serum oestradiol level nor the true degree of interaction was known, we simulated values of oestradiol and hypothetical levels of oestradiol-radiation interaction., Results: Compared with random sampling, power to detect interaction was similarly higher with either matching or counter matching with two or more controls., Conclusions: Because counter matching is generally at least as efficient as random sampling, whereas matching on exposure can result in loss of efficiency and precludes estimation of exposure risk, we recommend counter matching for selecting controls in nested case-control studies of the joint effects of multiple risk factors when one is previously measured in the full cohort.
- Published
- 2004
- Full Text
- View/download PDF
43. Uncertainty in estimating probability of causation in a cross-sectional study: joint effects of radiation and hepatitis-C virus on chronic liver disease.
- Author
-
Cologne JB, Pawel DJ, Sharp GB, and Fujiwara S
- Subjects
- Cross-Sectional Studies, Hepacivirus, Humans, Models, Theoretical, Hepatitis C, Chronic epidemiology, Hepatitis C, Chronic etiology, Radiation
- Abstract
Exposure to other risk factors is an important consideration in assessing the role played by radiation in producing disease. A cross-sectional study of atomic-bomb survivors suggested an interaction between whole-body radiation exposure and chronic hepatitis-C viral (HCV) infection in the etiology of chronic liver disease (chronic hepatitis and cirrhosis), but did not allow determination of the joint-effect mechanism. Different estimates of probability of causation (POC) conditional on HCV status resulted from additive and multiplicative models. We therefore estimated the risk for radiation conditional on HCV status using a more general, mixture model that does not require choosing between additivity or multiplicativity, or deciding whether there is interaction, in the face of the large uncertainty. The results support the conclusion that POC increases with radiation dose in persons without HCV infection, but are inconclusive regarding individuals with HCV infection, the lower confidence bound on estimated POC for radiation with HCV infection being zero over the entire dose range. Although the mixture model may not reflect the true joint-effect mechanism, it avoids restrictive model assumptions that cannot be validated using the available data yet have a profound influence on estimated POC. These considerations apply more generally, given that the additive and multiplicative models are often used in POC related work. We therefore consider that an empirical approach may be preferable to assuming a specific mechanistic model for estimating POC in epidemiological studies where the joint-effect mechanism is in doubt.
- Published
- 2004
- Full Text
- View/download PDF
44. Levetiracetam in the treatment of Lennox-Gastaut syndrome.
- Author
-
De Los Reyes EC, Sharp GB, Williams JP, and Hale SE
- Subjects
- Adolescent, Anticonvulsants adverse effects, Child, Child, Preschool, Drug Therapy, Combination, Epilepsy, Generalized diagnosis, Epilepsy, Tonic-Clonic diagnosis, Female, Humans, Intellectual Disability diagnosis, Intellectual Disability etiology, Levetiracetam, Male, Myoclonic Epilepsy, Juvenile diagnosis, Piracetam adverse effects, Piracetam analogs & derivatives, Retrospective Studies, Syndrome, Anticonvulsants administration & dosage, Epilepsy, Generalized drug therapy, Epilepsy, Tonic-Clonic drug therapy, Myoclonic Epilepsy, Juvenile drug therapy, Piracetam administration & dosage
- Abstract
Lennox-Gastaut syndrome is an epileptic encephalopathy characterized by multiple seizure types, mental retardation, and a slow spike-and-wave pattern on electroencephalography. Medical intractability is common. We identified a case series of six patients diagnosed with Lennox-Gastaut syndrome in which levetiracetam was initiated as add-on therapy for the management of seizures. At follow-up, four patients experienced 100% reduction of their myoclonic seizures; two patients had greater than 50% reduction of their atonic seizures, and four patients experienced 100% reduction in their generalized tonic-clonic seizures. Tonic seizures were not responsive to treatment. The most common side effect was irritability; the most positive change involved alertness. In this small sample, levetiracetam appeared effective in reducing seizures in Lennox-Gastaut syndrome. This preliminary study is limited by its retrospective design and small number of patients, but positive findings warrant a larger scale, multicenter study.
- Published
- 2004
- Full Text
- View/download PDF
45. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
- Author
-
Kambara T, Sharp GB, Nagasaka T, Takeda M, Sasamoto H, Nakagawa H, Isozaki H, MacPhee DG, Jass JR, Tanaka N, and Matsubara N
- Subjects
- Chromosome Mapping, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, DNA, Neoplasm genetics, DNA, Neoplasm isolation & purification, Disease-Free Survival, Humans, Neoplasm Staging, Sequence Deletion, Survival Analysis, Treatment Outcome, Chromosomes, Human, Pair 1 genetics, Colorectal Neoplasms genetics, Loss of Heterozygosity, Microsatellite Repeats genetics
- Abstract
Purpose: Allelic loss involving chromosome arms 5q, 8p, 17p, and 18q is commonly detected in colorectal cancer (CRC). The short arm of chromosome 1 is also frequently affected in a whole range of cancer types, including CRC. Our aim in the present study was to determine whether allelic losses on 1p were likely to be of much value in predicting the prognosis of CRC cases., Experimental Design: Genomic DNA was prepared from tumor and corresponding normal tissue specimens from 90 patients who had undergone curative resection for CRC. Loss of heterozygosity (LOH) on chromosome arms 1p, 2p, 5q, 7q, 8p, 17p, 17q, and 18q was examined using 14 microsatellite markers, and possible correlations between LOH and clinicopathological factors (including tumor recurrence and patient survival) were investigated. LOH at the MYCL1 microsatellite marker at 1p34 was detected in 12 of 74 (16.2%) patients who were informative for this marker., Results: After controlling for tumor stage and gender and excluding findings for patients with remote metastasis, we found that patients who were positive for LOH at MYCL1 were 31 times more likely to experience recurrence than those who were negative for LOH at this locus (95% confidence intervals, 2.27- infinity; P = 0.04). There were indications of a similar tendency for LOH at the 14-3-3-sigma-TG microsatellite marker at 1p35, but we could find no evidence of a significant association between LOH at this site and tumor recurrence or patient survival. We were also unable to detect significant association between LOH at the various sites on 2p, 5q, 7q, 8p, 17p, 17q, and 18q and either tumor recurrence or patient survival., Conclusions: CRC patients whose tumors exhibited LOH at MYCL1 at chromosome 1p34 were likely to have a poor prognosis, suggesting that this marker may have clinical relevance.
- Published
- 2004
- Full Text
- View/download PDF
46. Anxiety in children with epilepsy.
- Author
-
Williams J, Steel C, Sharp GB, DelosReyes E, Phillips T, Bates S, Lange B, and Griebel ML
- Subjects
- Adolescent, Antidepressive Agents therapeutic use, Anxiety drug therapy, Anxiety epidemiology, Anxiety ethnology, Child, Child Behavior Disorders, Comorbidity, Epilepsy drug therapy, Epilepsy ethnology, Female, Humans, Male, Neuropsychological Tests, Regression Analysis, Surveys and Questionnaires, Anxiety etiology, Epilepsy complications
- Abstract
Although the prevalence is unknown, affective disorders are more common in children with epilepsy than in healthy controls. The purpose of the present study was to examine the occurrence of anxiety in children and adolescents with epilepsy and to determine factors associated with elevation of these symptoms. Children and adolescents (n=101) between the ages of 6 and 16 years were given the Revised Children's Manifest Anxiety Scale (RCMAS). Mild to moderate symptoms of anxiety were reported by 23% of the patients. Based on regression analysis, factors significantly associated with increased anxiety included the presence of comorbid learning or behavioral difficulties, ethnicity, and polytherapy. Results suggest the need to monitor children and adolescents with epilepsy for affective symptoms in order to provide appropriate interventions.
- Published
- 2003
- Full Text
- View/download PDF
47. Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
- Author
-
Nagasaka T, Sharp GB, Notohara K, Kambara T, Sasamoto H, Isozaki H, MacPhee DG, Jass JR, Tanaka N, and Matsubara N
- Subjects
- Aged, Colon enzymology, Colorectal Neoplasms drug therapy, DNA Repair, Female, Gene Expression Regulation, Enzymologic, Gene Silencing, Humans, Male, Neoplasm Recurrence, Local drug therapy, Neoplasm Recurrence, Local enzymology, Predictive Value of Tests, Rectum enzymology, Colorectal Neoplasms enzymology, Colorectal Neoplasms genetics, DNA Methylation, Gene Expression Regulation, Neoplastic, Neoplasm Recurrence, Local genetics, O(6)-Methylguanine-DNA Methyltransferase genetics, Promoter Regions, Genetic
- Abstract
Purpose: Because O(6)-methylguanine-DNA methyltransferase (MGMT) plays an essential role in repairing DNA damage caused by environmental alkylating chemicals, we were interested in determining whether we could see any obvious changes in the properties of colorectal cancers (CRCs) in which the MGMT gene had been silenced by hypermethylation and hence in which very few MGMT protein molecules were being produced., Experimental Design: We used a methylation-specific PCR assay to determine the methylation status of the MGMT promoter in the DNA molecules extracted from CRC and nontumor tissue samples from 116 patients who had undergone CRC surgery and for whom clinical outcome information was available on file., Results: We found evidence of MGMT promoter hypermethylation in 26 of 90 CRC cases, and we noted that the later the stage at which a tumor was diagnosed, the less likely its MGMT promoter was to be methylated (P = 0.03, adjusting for chemotherapy), especially for stage D patients (P = 0.01). We also found that CRC patients with unmethylated MGMT promoters were much more likely to experience recurrence within 36 months than patients with hypermethylated MGMT promoters (crude odds ratio, 14.0; 95% confidence interval, 2.42-81.01). After adjustment for stage, CRC patients with unmethylated MGMT promoters who had been exposed to chemotherapy were found to have a 5.3-fold greater risk of recurrence than those who had no exposure to chemotherapy (95% confidence interval, 1.15-30.92)., Conclusions: Hypermethylation of the MGMT promoter may be predictive of a low risk of recurrence in CRC patients receiving adjuvant chemotherapy.
- Published
- 2003
48. Parental anxiety and quality of life in children with epilepsy.
- Author
-
Williams J, Steel C, Sharp GB, DelosReyes E, Phillips T, Bates S, Lange B, and Griebel ML
- Subjects
- Adolescent, Adult, Anxiety drug therapy, Child, Female, Humans, Male, Psychiatric Status Rating Scales, Sickness Impact Profile, Anxiety psychology, Epilepsy psychology, Parents psychology, Quality of Life psychology
- Abstract
Parental beliefs and attitudes concerning epilepsy may significantly impact adjustment and quality of life for both the child and family. The purpose of the present study was to examine the relationship between parental anxiety and quality of life in pediatric patients with ongoing epilepsy. Subjects were parents (n=200) of children between the ages of 6 and 16 years who had been diagnosed and treated for epilepsy for at least 1 year. Parents were given quality of life and anxiety questionnaires during the child's clinic visit. A stepwise regression analysis suggested that severity of comorbid conditions, parental anxiety, seizure control, and number of medications were significantly associated with quality of life for these children. Parents with increased anxiety whose children had poorly controlled seizures and a comorbid disability were found to have diminished quality of life.
- Published
- 2003
- Full Text
- View/download PDF
49. Prevalence of hepatitis B virus infection among atomic bomb survivors.
- Author
-
Fujiwara S, Sharp GB, Cologne JB, Kusumi S, Akahoshi M, Kodama K, Suzuki G, and Yoshizawa H
- Subjects
- Adult, Aged, Carrier State epidemiology, Dose-Response Relationship, Radiation, Female, Hepatitis B Antibodies blood, Hepatitis B Surface Antigens blood, Humans, Japan, Male, Middle Aged, Prevalence, Hepatitis B epidemiology, Nuclear Warfare
- Abstract
The aim of this study was to determine whether the prevalence of hepatitis B virus (HBV) carriers increased with atomic bomb radiation dose, and whether radiation decreased the ability to clear HBV among the atomic bomb survivors. The study subjects were 6,121 participants in the Adult Health Study of atomic bomb survivors in Hiroshima and Nagasaki. After adjustment for age, sex, city and potential confounders, the rates of seropositivity for hepatitis B surface antigen (HBsAg), indicating current HBV infections, and anti-hepatitis B core antibody, indicating either cured or current infections, increased with radiation dose. However, no relationship was observed between radiation and anti-hepatitis B surface antibody (indicating cured infection). The proportion of persons who were unable to clear the virus, as the proportion of HBsAg-positive persons among those ever infected by HBV (positive for HBsAg or surface or core hepatitis B antibody), increased significantly with radiation dose among those receiving blood transfusions. This proportion was not related to dose among those who reported no such transfusions. The findings may suggest a lower likelihood of clearance after HBV infection among those who were more likely to have been infected with HBV as adults after atomic bomb irradiation rather than as infants or adults prior to irradiation.
- Published
- 2003
- Full Text
- View/download PDF
50. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors.
- Author
-
Pierce DA, Sharp GB, and Mabuchi K
- Subjects
- Adult, Aged, Aged, 80 and over, Cohort Studies, Dose-Response Relationship, Radiation, Female, Follow-Up Studies, Humans, Incidence, Japan epidemiology, Lung Neoplasms etiology, Male, Middle Aged, Neoplasms, Radiation-Induced etiology, Radiation Dosage, Risk, Risk Factors, Sex Distribution, Cocarcinogenesis, Lung Neoplasms epidemiology, Neoplasms, Radiation-Induced epidemiology, Nuclear Warfare, Smoking adverse effects, Survivors
- Abstract
Results are given on the joint effect of radiation exposure and cigarette smoking on lung cancer risks among A-bomb survivors, based on 592 cases through 1994. Information on smoking was derived from mail surveys and clinical interviews of 45113 persons in the Radiation Effects Research Foundation cohort. Radiation and smoking effects on lung cancer are found to be significantly sub-multiplicative and quite consistent with additivity. The smoking relative risk, previously very low in studies of this cohort, is now similar to that found in Western populations. This increase is likely to be related to the scarcity of cigarettes during and after the war. The smoking relative risk depends little on sex. After adjusting for smoking, the radiation-related risks relative to background rates for nonsmokers are similar to those for other solid cancers: a sex-averaged ERR/Sv of about 0.9 with a female:male sex ratio of about 1.6. Adjusting for smoking removes a spuriously large female:male ratio in radiation relative risk due to confounding between sex and smoking level. The adjustment also removes an artifactual age-at-exposure effect in the radiation relative risk, opposite in direction to other cancers, which is due to birth cohort variation in lung cancer rates.
- Published
- 2003
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.